Apr 17 2026 This Week in Cardiology

SPIRIT-HF, another spironolactone trial in HFpEF; the ESSENCE imaging study of the drug olezarsen; the SirPAD trial in peripheral artery disease; and ultrasound-guided femoral venous access are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only . To read a partial transcript or to comment, visit: I ACC: SPIRIT-HF Trial FINEARTS-HF Trial TOPCAT Trial TOPCAT Americas Trial II A New Class of Lipid Lowering Drug Has a Dubious Debut At ACC ESSENCE-TIMI 73b Imaging Study ESSENCE-TIMI 73b Trial IMPROVE IT Trial III Drug-Coated Balloons Looked Quite Good in PAD interventions Sirolimus-Coated Balloon Reduces Amputation Risk in Peripheral Artery Disease SirPAD trial IV Another Vascular Story from the European Heart Rhythm Association ULYSSES Trial ULTRA-FAST Trial You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. Questions or feedback, please contact news@medscape.net

You can listen to Apr 17 2026 This Week in Cardiology online on Radio and Podcast. Open the player on this page to stream the available audio.

Apr 17 2026 This Week in Cardiology is an episode from This Week in Cardiology by Medscape Podcasts.

This episode is 28:12 long.

This episode was published on Apr 17, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from This Week in Cardiology when more episodes are available from the podcast feed.